SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,633,872 | -28.3% | 176,573 | +63.9% | 0.00% | -25.0% |
| Q2 2023 | $5,066,828 | -30.5% | 107,759 | -38.0% | 0.00% | -33.3% |
| Q1 2023 | $7,295,250 | +34.6% | 173,862 | +22.4% | 0.01% | +50.0% |
| Q4 2022 | $5,419,732 | -19.7% | 142,101 | -17.5% | 0.00% | -20.0% |
| Q3 2022 | $6,746,000 | +72.1% | 172,257 | +42.0% | 0.01% | +150.0% |
| Q2 2022 | $3,919,000 | +33.3% | 121,331 | +36.6% | 0.00% | +100.0% |
| Q1 2022 | $2,939,000 | -71.0% | 88,805 | -62.8% | 0.00% | -80.0% |
| Q4 2021 | $10,143,000 | +333.5% | 238,434 | +351.4% | 0.01% | +400.0% |
| Q3 2021 | $2,340,000 | -64.2% | 52,816 | -54.0% | 0.00% | -75.0% |
| Q2 2021 | $6,530,000 | +3.8% | 114,938 | +36.8% | 0.00% | 0.0% |
| Q1 2021 | $6,288,000 | -25.5% | 84,006 | -13.8% | 0.00% | -20.0% |
| Q4 2020 | $8,435,000 | +131.7% | 97,499 | +63.7% | 0.01% | +66.7% |
| Q3 2020 | $3,640,000 | -16.9% | 59,557 | -43.5% | 0.00% | 0.0% |
| Q2 2020 | $4,380,000 | +42.3% | 105,348 | -1.7% | 0.00% | 0.0% |
| Q1 2020 | $3,078,000 | -76.6% | 107,196 | -41.0% | 0.00% | -66.7% |
| Q4 2019 | $13,126,000 | -11.2% | 181,826 | +72.6% | 0.01% | -18.2% |
| Q3 2019 | $14,777,000 | -30.0% | 105,330 | -8.7% | 0.01% | -31.2% |
| Q2 2019 | $21,121,000 | +7.3% | 115,367 | -6.7% | 0.02% | -15.8% |
| Q1 2019 | $19,676,000 | +35.1% | 123,707 | -18.6% | 0.02% | +26.7% |
| Q4 2018 | $14,559,000 | -19.0% | 151,993 | +19.4% | 0.02% | -6.2% |
| Q3 2018 | $17,976,000 | +17.1% | 127,264 | +29.8% | 0.02% | +14.3% |
| Q2 2018 | $15,351,000 | +13.2% | 98,070 | +16.5% | 0.01% | +27.3% |
| Q1 2018 | $13,561,000 | -35.0% | 84,184 | -33.6% | 0.01% | -31.2% |
| Q4 2017 | $20,873,000 | +362.1% | 126,717 | +74.7% | 0.02% | +300.0% |
| Q3 2017 | $4,517,000 | -47.8% | 72,526 | -33.3% | 0.00% | -42.9% |
| Q2 2017 | $8,655,000 | -42.5% | 108,675 | -48.7% | 0.01% | -46.2% |
| Q1 2017 | $15,062,000 | +18.9% | 211,935 | -14.6% | 0.01% | +18.2% |
| Q4 2016 | $12,665,000 | +113.4% | 248,053 | +92.5% | 0.01% | +83.3% |
| Q3 2016 | $5,935,000 | +2200.4% | 128,873 | +1407.1% | 0.01% | – |
| Q2 2016 | $258,000 | -58.5% | 8,551 | -55.9% | 0.00% | -100.0% |
| Q1 2016 | $622,000 | +36.7% | 19,382 | +148.5% | 0.00% | – |
| Q4 2015 | $455,000 | -39.1% | 7,799 | -55.8% | 0.00% | -100.0% |
| Q3 2015 | $747,000 | +2.6% | 17,644 | +76.8% | 0.00% | 0.0% |
| Q2 2015 | $728,000 | +60.4% | 9,977 | +10.3% | 0.00% | – |
| Q1 2015 | $454,000 | -29.8% | 9,042 | -48.8% | 0.00% | -100.0% |
| Q4 2014 | $647,000 | +10683.3% | 17,656 | +8684.1% | 0.00% | – |
| Q3 2014 | $6,000 | – | 201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |